Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Furwax SA
- Development stage
- Preclinical
- Lead developer
- Entod Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
Furwax SA is a veterinary ear cleansing solution developed by Entod Pharmaceuticals (specifically through its Entod Vet division). It is designed for use in dogs and cats to facilitate the removal of ear wax (cerumen), debris, and necrotic tissue from the external ear canal. The "SA" in the product name refers to salicylic acid, which acts as a keratolytic and drying agent. By acidifying the ear canal and removing inflammatory secretions, Furwax SA helps maintain a healthy ear environment and is often used as a routine cleanser or as a preparatory step before the application of topical medications for the management of otitis externa.
- Brand names
- Furwax SA
- Other names
- Furwax SA Ear Cleanser
Beyond the preview
Go deeper on Furwax SA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Furwax SA.